Jefferies Raises Estimates/PT onSXC Health (SXCI) After Q4 Results; Stock Has Strong Legs

February 24, 2012 12:24 PM EST
Get Alerts SXCI Hot Sheet
Price: $93.02 --0%

Rating Summary:
    11 Buy, 6 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Jefferies boosted estimates and its price target on SXC Health Solutions (NASDAQ: SXCI) from $71 to $80 following Q4 results.

The firm comments, "SXC's robust growth outlook and operating momentum make it one of the most compelling stories in H/C. The company's proven ability to take advantage of PBM sector disruptions and gain share from its larger competitors, coupled with mgmt's success in driving incremental operating leverage should enable SXC to sustain its >30% EPS growth trajectory. With the stock trading at a 25% PE/G discount, we reiterate Buy, and take PT to $80."

For an analyst ratings summary and ratings history on SXC Health Solutions click here. For more ratings news on SXC Health Solutions click here.

Shares of SXC Health Solutions closed at $67.36 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

Jefferies & Co